Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2026(Status and Outlook)
Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis and, increasingly, for the therapy of diseases.Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours. Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.
The global Radiopharmaceuticals in Nuclear Medicine market size was estimated at USD 6678.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Radiopharmaceuticals in Nuclear Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Radiopharmaceuticals in Nuclear Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Radiopharmaceuticals in Nuclear Medicine market.
Global Radiopharmaceuticals in Nuclear Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Radiopharmaceuticals in Nuclear Medicine Market
Overview of the regional outlook of the Radiopharmaceuticals in Nuclear Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceuticals in Nuclear Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Radiopharmaceuticals in Nuclear Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Radiopharmaceuticals in Nuclear Medicine market size was estimated at USD 6678.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Radiopharmaceuticals in Nuclear Medicine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Radiopharmaceuticals in Nuclear Medicine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Radiopharmaceuticals in Nuclear Medicine market.
Global Radiopharmaceuticals in Nuclear Medicine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Bayer
Eli Lilly
Aurobindo Pharma
Mundipharma
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Radiopharmaceuticals in Nuclear Medicine Market
Overview of the regional outlook of the Radiopharmaceuticals in Nuclear Medicine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceuticals in Nuclear Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Radiopharmaceuticals in Nuclear Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Radiopharmaceuticals in Nuclear Medicine
1.2 Key Market Segments
1.2.1 Radiopharmaceuticals in Nuclear Medicine Segment by Type
1.2.2 Radiopharmaceuticals in Nuclear Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radiopharmaceuticals in Nuclear Medicine Product Life Cycle
3.3 Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2020-2025)
3.4 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends
3.8.1 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radiopharmaceuticals in Nuclear Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceuticals in Nuclear Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radiopharmaceuticals in Nuclear Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Radiopharmaceuticals in Nuclear Medicine Market
5.7 ESG Ratings of Leading Companies
6 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2020-2025)
6.3 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (2020-2025)
6.4 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2020-2025)
7 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceuticals in Nuclear Medicine Market Sales by Application (2020-2025)
7.3 Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Application (2020-2025)
8 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SALES BY REGION
8.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region
8.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.2.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.3 North America
8.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country
8.3.2 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country
8.4.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.5.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Radiopharmaceuticals in Nuclear Medicine Sales by Country
8.6.2 South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.7.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Radiopharmaceuticals in Nuclear Medicine by Region(2020-2025)
9.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Radiopharmaceuticals in Nuclear Medicine Production
9.4.1 North America Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2020-2025)
9.4.2 North America Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Radiopharmaceuticals in Nuclear Medicine Production
9.5.1 Europe Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Radiopharmaceuticals in Nuclear Medicine Production (2020-2025)
9.6.1 Japan Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Radiopharmaceuticals in Nuclear Medicine Production (2020-2025)
9.7.1 China Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2020-2025)
9.7.2 China Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product Overview
10.1.3 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product Overview
10.2.3 GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Jubilant Pharma
10.3.1 Jubilant Pharma Basic Information
10.3.2 Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
10.3.3 Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.3.4 Jubilant Pharma Business Overview
10.3.5 Jubilant Pharma SWOT Analysis
10.3.6 Jubilant Pharma Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Radiopharmaceuticals in Nuclear Medicine Product Overview
10.4.3 Novartis Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Curium Pharma
10.5.1 Curium Pharma Basic Information
10.5.2 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
10.5.3 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.5.4 Curium Pharma Business Overview
10.5.5 Curium Pharma Recent Developments
10.6 SIEMENS
10.6.1 SIEMENS Basic Information
10.6.2 SIEMENS Radiopharmaceuticals in Nuclear Medicine Product Overview
10.6.3 SIEMENS Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.6.4 SIEMENS Business Overview
10.6.5 SIEMENS Recent Developments
10.7 Lantheus
10.7.1 Lantheus Basic Information
10.7.2 Lantheus Radiopharmaceuticals in Nuclear Medicine Product Overview
10.7.3 Lantheus Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.7.4 Lantheus Business Overview
10.7.5 Lantheus Recent Developments
10.8 Bracco Imaging
10.8.1 Bracco Imaging Basic Information
10.8.2 Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product Overview
10.8.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.8.4 Bracco Imaging Business Overview
10.8.5 Bracco Imaging Recent Developments
10.9 Bayer
10.9.1 Bayer Basic Information
10.9.2 Bayer Radiopharmaceuticals in Nuclear Medicine Product Overview
10.9.3 Bayer Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product Overview
10.10.3 Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Basic Information
10.11.2 Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
10.11.3 Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.11.4 Aurobindo Pharma Business Overview
10.11.5 Aurobindo Pharma Recent Developments
10.12 Mundipharma
10.12.1 Mundipharma Basic Information
10.12.2 Mundipharma Radiopharmaceuticals in Nuclear Medicine Product Overview
10.12.3 Mundipharma Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.12.4 Mundipharma Business Overview
10.12.5 Mundipharma Recent Developments
10.13 China Isotope and Radiation
10.13.1 China Isotope and Radiation Basic Information
10.13.2 China Isotope and Radiation Radiopharmaceuticals in Nuclear Medicine Product Overview
10.13.3 China Isotope and Radiation Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.13.4 China Isotope and Radiation Business Overview
10.13.5 China Isotope and Radiation Recent Developments
10.14 Dongcheng
10.14.1 Dongcheng Basic Information
10.14.2 Dongcheng Radiopharmaceuticals in Nuclear Medicine Product Overview
10.14.3 Dongcheng Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.14.4 Dongcheng Business Overview
10.14.5 Dongcheng Recent Developments
11 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET FORECAST BY REGION
11.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast
11.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region
11.2.4 South America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Radiopharmaceuticals in Nuclear Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Radiopharmaceuticals in Nuclear Medicine by Type (2026-2035)
12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Radiopharmaceuticals in Nuclear Medicine by Type (2026-2035)
12.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) Forecast by Application
12.2.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Radiopharmaceuticals in Nuclear Medicine
1.2 Key Market Segments
1.2.1 Radiopharmaceuticals in Nuclear Medicine Segment by Type
1.2.2 Radiopharmaceuticals in Nuclear Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radiopharmaceuticals in Nuclear Medicine Product Life Cycle
3.3 Global Radiopharmaceuticals in Nuclear Medicine Sales by Manufacturers (2020-2025)
3.4 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radiopharmaceuticals in Nuclear Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Radiopharmaceuticals in Nuclear Medicine Market Competitive Situation and Trends
3.8.1 Radiopharmaceuticals in Nuclear Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radiopharmaceuticals in Nuclear Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceuticals in Nuclear Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radiopharmaceuticals in Nuclear Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Radiopharmaceuticals in Nuclear Medicine Market
5.7 ESG Ratings of Leading Companies
6 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2020-2025)
6.3 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (2020-2025)
6.4 Global Radiopharmaceuticals in Nuclear Medicine Price by Type (2020-2025)
7 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceuticals in Nuclear Medicine Market Sales by Application (2020-2025)
7.3 Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) by Application (2020-2025)
7.4 Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Application (2020-2025)
8 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SALES BY REGION
8.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region
8.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.2.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.2.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.3 North America
8.3.1 North America Radiopharmaceuticals in Nuclear Medicine Sales by Country
8.3.2 North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country
8.4.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.5.2 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Radiopharmaceuticals in Nuclear Medicine Sales by Country
8.6.2 South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Region
8.7.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Radiopharmaceuticals in Nuclear Medicine by Region(2020-2025)
9.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2020-2025)
9.3 Global Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Radiopharmaceuticals in Nuclear Medicine Production
9.4.1 North America Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2020-2025)
9.4.2 North America Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Radiopharmaceuticals in Nuclear Medicine Production
9.5.1 Europe Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2020-2025)
9.5.2 Europe Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Radiopharmaceuticals in Nuclear Medicine Production (2020-2025)
9.6.1 Japan Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2020-2025)
9.6.2 Japan Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Radiopharmaceuticals in Nuclear Medicine Production (2020-2025)
9.7.1 China Radiopharmaceuticals in Nuclear Medicine Production Growth Rate (2020-2025)
9.7.2 China Radiopharmaceuticals in Nuclear Medicine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Cardinal Health
10.1.1 Cardinal Health Basic Information
10.1.2 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product Overview
10.1.3 Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.1.4 Cardinal Health Business Overview
10.1.5 Cardinal Health SWOT Analysis
10.1.6 Cardinal Health Recent Developments
10.2 GE Healthcare
10.2.1 GE Healthcare Basic Information
10.2.2 GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product Overview
10.2.3 GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.2.4 GE Healthcare Business Overview
10.2.5 GE Healthcare SWOT Analysis
10.2.6 GE Healthcare Recent Developments
10.3 Jubilant Pharma
10.3.1 Jubilant Pharma Basic Information
10.3.2 Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
10.3.3 Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.3.4 Jubilant Pharma Business Overview
10.3.5 Jubilant Pharma SWOT Analysis
10.3.6 Jubilant Pharma Recent Developments
10.4 Novartis
10.4.1 Novartis Basic Information
10.4.2 Novartis Radiopharmaceuticals in Nuclear Medicine Product Overview
10.4.3 Novartis Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.4.4 Novartis Business Overview
10.4.5 Novartis Recent Developments
10.5 Curium Pharma
10.5.1 Curium Pharma Basic Information
10.5.2 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
10.5.3 Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.5.4 Curium Pharma Business Overview
10.5.5 Curium Pharma Recent Developments
10.6 SIEMENS
10.6.1 SIEMENS Basic Information
10.6.2 SIEMENS Radiopharmaceuticals in Nuclear Medicine Product Overview
10.6.3 SIEMENS Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.6.4 SIEMENS Business Overview
10.6.5 SIEMENS Recent Developments
10.7 Lantheus
10.7.1 Lantheus Basic Information
10.7.2 Lantheus Radiopharmaceuticals in Nuclear Medicine Product Overview
10.7.3 Lantheus Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.7.4 Lantheus Business Overview
10.7.5 Lantheus Recent Developments
10.8 Bracco Imaging
10.8.1 Bracco Imaging Basic Information
10.8.2 Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product Overview
10.8.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.8.4 Bracco Imaging Business Overview
10.8.5 Bracco Imaging Recent Developments
10.9 Bayer
10.9.1 Bayer Basic Information
10.9.2 Bayer Radiopharmaceuticals in Nuclear Medicine Product Overview
10.9.3 Bayer Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.9.4 Bayer Business Overview
10.9.5 Bayer Recent Developments
10.10 Eli Lilly
10.10.1 Eli Lilly Basic Information
10.10.2 Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product Overview
10.10.3 Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.10.4 Eli Lilly Business Overview
10.10.5 Eli Lilly Recent Developments
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Basic Information
10.11.2 Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
10.11.3 Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.11.4 Aurobindo Pharma Business Overview
10.11.5 Aurobindo Pharma Recent Developments
10.12 Mundipharma
10.12.1 Mundipharma Basic Information
10.12.2 Mundipharma Radiopharmaceuticals in Nuclear Medicine Product Overview
10.12.3 Mundipharma Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.12.4 Mundipharma Business Overview
10.12.5 Mundipharma Recent Developments
10.13 China Isotope and Radiation
10.13.1 China Isotope and Radiation Basic Information
10.13.2 China Isotope and Radiation Radiopharmaceuticals in Nuclear Medicine Product Overview
10.13.3 China Isotope and Radiation Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.13.4 China Isotope and Radiation Business Overview
10.13.5 China Isotope and Radiation Recent Developments
10.14 Dongcheng
10.14.1 Dongcheng Basic Information
10.14.2 Dongcheng Radiopharmaceuticals in Nuclear Medicine Product Overview
10.14.3 Dongcheng Radiopharmaceuticals in Nuclear Medicine Product Market Performance
10.14.4 Dongcheng Business Overview
10.14.5 Dongcheng Recent Developments
11 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET FORECAST BY REGION
11.1 Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast
11.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region
11.2.4 South America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Radiopharmaceuticals in Nuclear Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Radiopharmaceuticals in Nuclear Medicine by Type (2026-2035)
12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Radiopharmaceuticals in Nuclear Medicine by Type (2026-2035)
12.2 Global Radiopharmaceuticals in Nuclear Medicine Market Forecast by Application (2026-2035)
12.2.1 Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) Forecast by Application
12.2.2 Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (M USD)
Table 4. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application
Table 5. Radiopharmaceuticals in Nuclear Medicine Market Size Comparison by Region (M USD)
Table 6. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2025)
Table 11. Global Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceuticals in Nuclear Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (K MT)
Table 27. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (M USD)
Table 28. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2020-2025)
Table 32. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Application
Table 34. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application
Table 35. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application (2020-2025)
Table 39. Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025)
Table 44. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Radiopharmaceuticals in Nuclear Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cardinal Health Basic Information
Table 63. Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 64. Cardinal Health Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. GE Healthcare Basic Information
Table 69. GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 70. GE Healthcare Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare SWOT Analysis
Table 73. GE Healthcare Recent Developments
Table 74. Jubilant Pharma Basic Information
Table 75. Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 76. Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Jubilant Pharma Business Overview
Table 78. Jubilant Pharma SWOT Analysis
Table 79. Jubilant Pharma Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 82. Novartis Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Curium Pharma Basic Information
Table 86. Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 87. Curium Pharma Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Curium Pharma Business Overview
Table 89. Curium Pharma Recent Developments
Table 90. SIEMENS Basic Information
Table 91. SIEMENS Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 92. SIEMENS Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. SIEMENS Business Overview
Table 94. SIEMENS Recent Developments
Table 95. Lantheus Basic Information
Table 96. Lantheus Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 97. Lantheus Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Lantheus Business Overview
Table 99. Lantheus Recent Developments
Table 100. Bracco Imaging Basic Information
Table 101. Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 102. Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bracco Imaging Business Overview
Table 104. Bracco Imaging Recent Developments
Table 105. Bayer Basic Information
Table 106. Bayer Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 107. Bayer Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Bayer Business Overview
Table 109. Bayer Recent Developments
Table 110. Eli Lilly Basic Information
Table 111. Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 112. Eli Lilly Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Recent Developments
Table 115. Aurobindo Pharma Basic Information
Table 116. Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 117. Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Aurobindo Pharma Business Overview
Table 119. Aurobindo Pharma Recent Developments
Table 120. Mundipharma Basic Information
Table 121. Mundipharma Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 122. Mundipharma Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Mundipharma Business Overview
Table 124. Mundipharma Recent Developments
Table 125. China Isotope and Radiation Basic Information
Table 126. China Isotope and Radiation Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 127. China Isotope and Radiation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. China Isotope and Radiation Business Overview
Table 129. China Isotope and Radiation Recent Developments
Table 130. Dongcheng Basic Information
Table 131. Dongcheng Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 132. Dongcheng Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Dongcheng Business Overview
Table 134. Dongcheng Recent Developments
Table 135. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (M USD)
Table 4. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application
Table 5. Radiopharmaceuticals in Nuclear Medicine Market Size Comparison by Region (M USD)
Table 6. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals in Nuclear Medicine as of 2025)
Table 11. Global Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Radiopharmaceuticals in Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceuticals in Nuclear Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Radiopharmaceuticals in Nuclear Medicine Sales by Type (K MT)
Table 27. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Type (M USD)
Table 28. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Type (2020-2025)
Table 29. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2020-2025)
Table 30. Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) by Type (2020-2025)
Table 31. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2020-2025)
Table 32. Global Radiopharmaceuticals in Nuclear Medicine Price (USD/KG) by Type (2020-2025)
Table 33. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) by Application
Table 34. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application
Table 35. Global Radiopharmaceuticals in Nuclear Medicine Sales by Application (2020-2025) & (K MT)
Table 36. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2020-2025)
Table 37. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application (2020-2025)
Table 39. Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Application (2020-2025)
Table 40. Global Radiopharmaceuticals in Nuclear Medicine Sales by Region (2020-2025) & (K MT)
Table 41. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2020-2025)
Table 42. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025)
Table 44. North America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2020-2025) & (K MT)
Table 45. North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Radiopharmaceuticals in Nuclear Medicine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Radiopharmaceuticals in Nuclear Medicine Sales by Country (2020-2025) & (K MT)
Table 51. South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Radiopharmaceuticals in Nuclear Medicine Production (K MT) by Region(2020-2025)
Table 55. Global Radiopharmaceuticals in Nuclear Medicine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Region (2020-2025)
Table 57. Global Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Radiopharmaceuticals in Nuclear Medicine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Cardinal Health Basic Information
Table 63. Cardinal Health Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 64. Cardinal Health Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health SWOT Analysis
Table 67. Cardinal Health Recent Developments
Table 68. GE Healthcare Basic Information
Table 69. GE Healthcare Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 70. GE Healthcare Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GE Healthcare Business Overview
Table 72. GE Healthcare SWOT Analysis
Table 73. GE Healthcare Recent Developments
Table 74. Jubilant Pharma Basic Information
Table 75. Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 76. Jubilant Pharma Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Jubilant Pharma Business Overview
Table 78. Jubilant Pharma SWOT Analysis
Table 79. Jubilant Pharma Recent Developments
Table 80. Novartis Basic Information
Table 81. Novartis Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 82. Novartis Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Business Overview
Table 84. Novartis Recent Developments
Table 85. Curium Pharma Basic Information
Table 86. Curium Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 87. Curium Pharma Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Curium Pharma Business Overview
Table 89. Curium Pharma Recent Developments
Table 90. SIEMENS Basic Information
Table 91. SIEMENS Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 92. SIEMENS Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. SIEMENS Business Overview
Table 94. SIEMENS Recent Developments
Table 95. Lantheus Basic Information
Table 96. Lantheus Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 97. Lantheus Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Lantheus Business Overview
Table 99. Lantheus Recent Developments
Table 100. Bracco Imaging Basic Information
Table 101. Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 102. Bracco Imaging Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bracco Imaging Business Overview
Table 104. Bracco Imaging Recent Developments
Table 105. Bayer Basic Information
Table 106. Bayer Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 107. Bayer Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Bayer Business Overview
Table 109. Bayer Recent Developments
Table 110. Eli Lilly Basic Information
Table 111. Eli Lilly Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 112. Eli Lilly Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eli Lilly Business Overview
Table 114. Eli Lilly Recent Developments
Table 115. Aurobindo Pharma Basic Information
Table 116. Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 117. Aurobindo Pharma Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Aurobindo Pharma Business Overview
Table 119. Aurobindo Pharma Recent Developments
Table 120. Mundipharma Basic Information
Table 121. Mundipharma Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 122. Mundipharma Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Mundipharma Business Overview
Table 124. Mundipharma Recent Developments
Table 125. China Isotope and Radiation Basic Information
Table 126. China Isotope and Radiation Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 127. China Isotope and Radiation Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. China Isotope and Radiation Business Overview
Table 129. China Isotope and Radiation Recent Developments
Table 130. Dongcheng Basic Information
Table 131. Dongcheng Radiopharmaceuticals in Nuclear Medicine Product Overview
Table 132. Dongcheng Radiopharmaceuticals in Nuclear Medicine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Dongcheng Business Overview
Table 134. Dongcheng Recent Developments
Table 135. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Radiopharmaceuticals in Nuclear Medicine Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radiopharmaceuticals in Nuclear Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD), 2025-2035
Figure 5. Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceuticals in Nuclear Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radiopharmaceuticals in Nuclear Medicine Product Life Cycle
Figure 13. Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers in 2025
Figure 15. Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceuticals in Nuclear Medicine Revenue in 2025
Figure 18. Industry Chain Map of Radiopharmaceuticals in Nuclear Medicine
Figure 19. Global Radiopharmaceuticals in Nuclear Medicine Market PEST Analysis
Figure 20. Global Radiopharmaceuticals in Nuclear Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type
Figure 27. Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Type in 2025
Figure 29. Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2020-2025)
Figure 30. Market Share of Radiopharmaceuticals in Nuclear Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application
Figure 33. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2025
Figure 35. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application (2020-2025)
Figure 36. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2025
Figure 37. Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025)
Figure 40. North America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2024
Figure 43. North America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country in 2024
Figure 45. U.S. Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Radiopharmaceuticals in Nuclear Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Radiopharmaceuticals in Nuclear Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Radiopharmaceuticals in Nuclear Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2024
Figure 53. Europe Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country in 2024
Figure 55. Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region in 2024
Figure 68. China Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (K MT)
Figure 79. South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2024
Figure 80. South America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country in 2024
Figure 82. Brazil Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Radiopharmaceuticals in Nuclear Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Radiopharmaceuticals in Nuclear Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Radiopharmaceuticals in Nuclear Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Radiopharmaceuticals in Nuclear Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Radiopharmaceuticals in Nuclear Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD), 2025-2035
Figure 5. Global Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) (2020-2035)
Figure 6. Global Radiopharmaceuticals in Nuclear Medicine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceuticals in Nuclear Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radiopharmaceuticals in Nuclear Medicine Product Life Cycle
Figure 13. Radiopharmaceuticals in Nuclear Medicine Sales Share by Manufacturers in 2025
Figure 14. Global Radiopharmaceuticals in Nuclear Medicine Revenue Share by Manufacturers in 2025
Figure 15. Radiopharmaceuticals in Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Radiopharmaceuticals in Nuclear Medicine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceuticals in Nuclear Medicine Revenue in 2025
Figure 18. Industry Chain Map of Radiopharmaceuticals in Nuclear Medicine
Figure 19. Global Radiopharmaceuticals in Nuclear Medicine Market PEST Analysis
Figure 20. Global Radiopharmaceuticals in Nuclear Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type
Figure 27. Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2020-2025)
Figure 28. Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Type in 2025
Figure 29. Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2020-2025)
Figure 30. Market Share of Radiopharmaceuticals in Nuclear Medicine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application
Figure 33. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2020-2025)
Figure 34. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2025
Figure 35. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application (2020-2025)
Figure 36. Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2025
Figure 37. Global Radiopharmaceuticals in Nuclear Medicine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region (2020-2025)
Figure 39. Global Radiopharmaceuticals in Nuclear Medicine Market Size by Region (2020-2025)
Figure 40. North America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2024
Figure 43. North America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Radiopharmaceuticals in Nuclear Medicine Market Size by Country in 2024
Figure 45. U.S. Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Radiopharmaceuticals in Nuclear Medicine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Radiopharmaceuticals in Nuclear Medicine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Radiopharmaceuticals in Nuclear Medicine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Radiopharmaceuticals in Nuclear Medicine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2024
Figure 53. Europe Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Radiopharmaceuticals in Nuclear Medicine Market Size by Country in 2024
Figure 55. Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Radiopharmaceuticals in Nuclear Medicine Market Size by Region in 2024
Figure 68. China Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (K MT)
Figure 79. South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Country in 2024
Figure 80. South America Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (M USD)
Figure 81. South America Radiopharmaceuticals in Nuclear Medicine Market Size by Country in 2024
Figure 82. Brazil Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Radiopharmaceuticals in Nuclear Medicine Market Size by Region in 2024
Figure 92. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Radiopharmaceuticals in Nuclear Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Radiopharmaceuticals in Nuclear Medicine Production Market Share by Region (2020-2025)
Figure 103. North America Radiopharmaceuticals in Nuclear Medicine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Radiopharmaceuticals in Nuclear Medicine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Radiopharmaceuticals in Nuclear Medicine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Radiopharmaceuticals in Nuclear Medicine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Radiopharmaceuticals in Nuclear Medicine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Type (2026-2035)
Figure 111. Global Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2026-2035)
Figure 112. Global Radiopharmaceuticals in Nuclear Medicine Market Share Forecast by Application (2026-2035)
